Uzbekistan’s annual need for pediatric bone marrow transplants is currently met by less than 10%, Health Minister Eldor Adilov said on November 11 during a “Government Hour” session at the Legislative Chamber of the Oliy Majlis. According to the minister, 32 transplants were performed in 2025, while the figure stood at 36 as of November 1, 2026, against a minimum estimated annual need of 400 children. The figures indicate that the country’s pediatric transplant service remains far below actual demand, despite the existence of a legal framework for such procedures.
Key Takeaways: In 2025, 32 bone marrow transplants were performed; as of November 1, 2026, the figure was 36, while the minimum annual need is 400 children. Of the 36 operations this year, 12 were carried out in Turkey, 13 at the National Children’s Medical Center and 11 at the Republican Children’s Oncology, Hematology and Immunology Scientific-Practical Medical Center. Twenty-eight procedures were allogeneic and eight were autologous.
The parliamentary discussion highlighted a gap between legislation and practical capacity. In 2022, Uzbekistan adopted the law “On Transplantation of Human Organs and Tissues,” creating a legal basis for such operations. Lawmaker Zebiniso Rahmanova asked why bone marrow transplant capacity remains limited despite the law and what measures are being taken to increase the number of procedures. For children with certain oncological, hematological and immunological conditions, bone marrow transplantation can be a life-saving treatment, making the issue a matter of access to high-tech medical care as well as health-sector statistics.
Adilov outlined three main barriers. The first is the lack of infrastructure for performing transplants at scale. Construction of an aseptic building continues on the territory of the Republican Children’s Oncology, Hematology and Immunology Scientific-Practical Medical Center. It is intended to house a transplant department and a typing laboratory that determines donor-patient cell compatibility. According to the Legislative Chamber, the facility’s construction has been delayed by more than two years. The minister said that once the building is commissioned, the number of transplants could rise sharply.
“We have a need to perform bone marrow transplantation for at least 400 children a year. But today we have not been able to reach 400 such transplant procedures,” Adilov said. He explained that changes were made to the construction project: Austria’s AMI International was engaged, and its specialists helped develop the building design in line with European standards. Completion and commissioning are planned for 2027. Adilov also stressed that technical capacity alone is not enough; post-transplant patient survival depends on special sterile conditions, laboratory diagnostics, infection control and follow-up care.
The second barrier is the absence of a national bone marrow donor registry. Allogeneic transplantation requires selecting a donor whose stem cells match the patient, and a registry would allow potential donors to be sought systematically and tested as needed. “To carry out these transplants, we need to maintain a national registry of bone marrow donors. Today this work has begun,” Adilov said. The report did not provide full details on the third barrier, so additional official information is required.
The session indicates that Uzbekistan’s next steps will focus on completing the aseptic building, establishing the institutional framework for a donor registry and gradually expanding transplant volumes. Official updates are expected on the construction timeline, the registry’s operation and measures to improve access to pediatric bone marrow transplantation. The issue is likely to remain on the parliamentary agenda because the current gap between 36 procedures and the minimum annual need of 400 children is substantial and directly affects patients and families.
Source: www.gazeta.uz